Irina Marić

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

James N. Kochenderfer, Mark E. Dudley, Steven A. Feldman et al. · Blood · 2011 · 1.4K citations

Life Sciences, Hematology, Immunology +17

Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19

James N. Kochenderfer, Wyndham H. Wilson, John E. Janik et al. · Blood · 2010 · 1.3K citations · Full text

Medicine, Hematology, Oncology +14

The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia

Yair Herishanu, Patricia Pérez‐Galán, Delong Liu et al. · Blood · 2010 · 815 citations

Medicine, Molecular Biology, Oncology +16

T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Jennifer N. Brudno, Irina Marić, Steven D. Hartman et al. · Journal of Clinical Oncology · 2018 · 791 citations · Full text

Medicine, Hematology, Immunology +15

T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

Syed Abbas Ali, Victoria Shi, Irina Marić et al. · Blood · 2016 · 766 citations · Full text

Life Sciences, Immunology, Oncology +14